Colorado Stories
-
Coloradans with disabilities share how they have navigated the pandemic, and what they want the world to look like after it's over.
-
Fully vaccinated Coloradans can now go without masks in most public settings unless a specific business or local regulation requires otherwise, Gov. Jared Polis said Friday. The announcement comes on the heels of the Centers for Disease Control’s new guidance that vaccinated people can safely stop wearing masks.
-
Sandra Kunz had been worried for her safety while working as a cashier at a Walmart in Aurora, Colorado, during the pandemic, said her sister, Paula Spellman.
-
Some health officials in Colorado have warned that continued high numbers of COVID-19 hospitalizations point to the pandemic not being over yet despite the state's average infection rate decreasing by nearly a third since April.
-
A recent poll by the Kaiser Family Foundation found Black and Hispanic adults surveyed worry about missing work due to side effects, paying out-of-pocket for the free vaccine, or finding a reputable clinic to obtain the shot.
National Stories
-
Biden's comments — made as officials try to convince Americans to get a new booster shot and the White House seeks $22 billion in new COVID funding — were "unfortunate," several epidemiologists said.
-
They argue the threat posed by COVID has lessened because of preexisting immunity and access to treatment. Plus, some deaths may be incorrectly blamed on COVID. Others caution it's too soon to tell.
-
A new study suggests that. yes, there are superdodgers. But explaining why they've been able to avoid the virus is a bit complicated.
-
Sikhulile Moyo led the team that first identified omicron — and was dismayed by the world's reaction — blaming and blacklisting African nations. He's now a bit more optimistic.
-
People can get the Moderna booster if they're 18 or older, and the Pfizer-BioNTech version if they're 12 and up. In both cases, they must wait at least two months since their last COVID vaccine.
-
The inventors of Corbevax said it was cheap, easy to make, effective and safe. They hoped it could bring vaccine equity to countries that can't access costlier shots. Has it lived up to its promise?